0001174891 false Q3 --12-31 0001174891 2022-01-01 2022-09-30 0001174891 2022-11-03 0001174891 2022-09-30 0001174891 2021-12-31 0001174891 BUUZ:SeriesAConvertiblePreferredStockMember 2022-09-30 0001174891 BUUZ:SeriesAConvertiblePreferredStockMember 2021-12-31 0001174891 2022-07-01 2022-09-30 0001174891 2021-07-01 2021-09-30 0001174891 2021-01-01 2021-09-30 0001174891 us-gaap:PreferredStockMember BUUZ:SeriesAConvertiblePreferredStockMember 2021-12-31 0001174891 us-gaap:PreferredStockMember 2021-12-31 0001174891 us-gaap:CommonStockMember 2021-12-31 0001174891 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001174891 BUUZ:StockSubscriptionReceivableMember 2021-12-31 0001174891 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001174891 us-gaap:RetainedEarningsMember 2021-12-31 0001174891 us-gaap:PreferredStockMember BUUZ:SeriesAConvertiblePreferredStockMember 2022-03-31 0001174891 us-gaap:PreferredStockMember 2022-03-31 0001174891 us-gaap:CommonStockMember 2022-03-31 0001174891 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001174891 BUUZ:StockSubscriptionReceivableMember 2022-03-31 0001174891 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001174891 us-gaap:RetainedEarningsMember 2022-03-31 0001174891 2022-03-31 0001174891 us-gaap:PreferredStockMember BUUZ:SeriesAConvertiblePreferredStockMember 2022-06-30 0001174891 us-gaap:PreferredStockMember 2022-06-30 0001174891 us-gaap:CommonStockMember 2022-06-30 0001174891 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001174891 BUUZ:StockSubscriptionReceivableMember 2022-06-30 0001174891 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001174891 us-gaap:RetainedEarningsMember 2022-06-30 0001174891 2022-06-30 0001174891 us-gaap:PreferredStockMember BUUZ:SeriesAConvertiblePreferredStockMember 2020-12-31 0001174891 us-gaap:PreferredStockMember 2020-12-31 0001174891 us-gaap:CommonStockMember 2020-12-31 0001174891 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001174891 BUUZ:StockSubscriptionReceivableMember 2020-12-31 0001174891 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001174891 us-gaap:RetainedEarningsMember 2020-12-31 0001174891 2020-12-31 0001174891 us-gaap:PreferredStockMember BUUZ:SeriesAConvertiblePreferredStockMember 2021-03-31 0001174891 us-gaap:PreferredStockMember 2021-03-31 0001174891 us-gaap:CommonStockMember 2021-03-31 0001174891 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001174891 BUUZ:StockSubscriptionReceivableMember 2021-03-31 0001174891 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0001174891 us-gaap:RetainedEarningsMember 2021-03-31 0001174891 2021-03-31 0001174891 us-gaap:PreferredStockMember BUUZ:SeriesAConvertiblePreferredStockMember 2021-06-30 0001174891 us-gaap:PreferredStockMember 2021-06-30 0001174891 us-gaap:CommonStockMember 2021-06-30 0001174891 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001174891 BUUZ:StockSubscriptionReceivableMember 2021-06-30 0001174891 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0001174891 us-gaap:RetainedEarningsMember 2021-06-30 0001174891 2021-06-30 0001174891 us-gaap:PreferredStockMember BUUZ:SeriesAConvertiblePreferredStockMember 2022-01-01 2022-03-31 0001174891 us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0001174891 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001174891 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001174891 BUUZ:StockSubscriptionReceivableMember 2022-01-01 2022-03-31 0001174891 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0001174891 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001174891 2022-01-01 2022-03-31 0001174891 us-gaap:PreferredStockMember BUUZ:SeriesAConvertiblePreferredStockMember 2022-04-01 2022-06-30 0001174891 us-gaap:PreferredStockMember 2022-04-01 2022-06-30 0001174891 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001174891 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001174891 BUUZ:StockSubscriptionReceivableMember 2022-04-01 2022-06-30 0001174891 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-04-01 2022-06-30 0001174891 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001174891 2022-04-01 2022-06-30 0001174891 us-gaap:PreferredStockMember BUUZ:SeriesAConvertiblePreferredStockMember 2022-07-01 2022-09-30 0001174891 us-gaap:PreferredStockMember 2022-07-01 2022-09-30 0001174891 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001174891 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001174891 BUUZ:StockSubscriptionReceivableMember 2022-07-01 2022-09-30 0001174891 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-01 2022-09-30 0001174891 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001174891 us-gaap:PreferredStockMember BUUZ:SeriesAConvertiblePreferredStockMember 2021-01-01 2021-03-31 0001174891 us-gaap:PreferredStockMember 2021-01-01 2021-03-31 0001174891 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001174891 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001174891 BUUZ:StockSubscriptionReceivableMember 2021-01-01 2021-03-31 0001174891 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0001174891 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001174891 2021-01-01 2021-03-31 0001174891 us-gaap:PreferredStockMember BUUZ:SeriesAConvertiblePreferredStockMember 2021-04-01 2021-06-30 0001174891 us-gaap:PreferredStockMember 2021-04-01 2021-06-30 0001174891 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001174891 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001174891 BUUZ:StockSubscriptionReceivableMember 2021-04-01 2021-06-30 0001174891 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-01 2021-06-30 0001174891 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001174891 2021-04-01 2021-06-30 0001174891 us-gaap:PreferredStockMember BUUZ:SeriesAConvertiblePreferredStockMember 2021-07-01 2021-09-30 0001174891 us-gaap:PreferredStockMember 2021-07-01 2021-09-30 0001174891 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001174891 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001174891 BUUZ:StockSubscriptionReceivableMember 2021-07-01 2021-09-30 0001174891 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-01 2021-09-30 0001174891 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001174891 us-gaap:PreferredStockMember BUUZ:SeriesAConvertiblePreferredStockMember 2022-09-30 0001174891 us-gaap:PreferredStockMember 2022-09-30 0001174891 us-gaap:CommonStockMember 2022-09-30 0001174891 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001174891 BUUZ:StockSubscriptionReceivableMember 2022-09-30 0001174891 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0001174891 us-gaap:RetainedEarningsMember 2022-09-30 0001174891 us-gaap:PreferredStockMember BUUZ:SeriesAConvertiblePreferredStockMember 2021-09-30 0001174891 us-gaap:PreferredStockMember 2021-09-30 0001174891 us-gaap:CommonStockMember 2021-09-30 0001174891 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001174891 BUUZ:StockSubscriptionReceivableMember 2021-09-30 0001174891 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0001174891 us-gaap:RetainedEarningsMember 2021-09-30 0001174891 2021-09-30 0001174891 BUUZ:AIQMember 2021-11-05 0001174891 2021-11-04 2021-11-05 0001174891 country:KR BUUZ:AIQMember 2021-11-04 2021-11-05 0001174891 country:KR BUUZ:AIQMember 2021-11-05 0001174891 BUUZ:TechnologyDevelopmentAgreementMember BUUZ:PICOCELCoLtdMember 2021-12-23 2021-12-23 0001174891 BUUZ:TechnologyDevelopmentAgreementMember BUUZ:PICOCELCoLtdMember 2022-01-01 2022-09-30 0001174891 BUUZ:AIQMember 2022-04-05 0001174891 BUUZ:AIQMember 2022-09-30 0001174891 BUUZ:ValueAddedTaxMember 2022-01-01 2022-09-30 0001174891 BUUZ:WithinFiveDaysAfterSigningTheContractMember 2022-04-05 0001174891 BUUZ:WithinFiveDaysAfterallConditionsAreMetMember 2022-04-05 0001174891 2022-04-05 0001174891 BUUZ:PICOCELMember BUUZ:AmountMember 2022-09-30 0001174891 BUUZ:PICOCELMember BUUZ:ValueAddedTaxMember 2022-09-30 0001174891 BUUZ:PICOCELMember 2022-09-30 0001174891 BUUZ:NNSMember BUUZ:AmountMember 2022-09-30 0001174891 BUUZ:NNSMember BUUZ:ValueAddedTaxMember 2022-09-30 0001174891 BUUZ:NNSMember 2022-09-30 0001174891 BUUZ:AmountMember 2022-09-30 0001174891 BUUZ:ValueAddedTaxMember 2022-09-30 0001174891 BUUZ:AmountMember 2022-01-01 2022-09-30 0001174891 2021-01-01 2021-12-31 0001174891 BUUZ:PromissoryNoteMember 2020-07-07 0001174891 BUUZ:PromissoryNoteMember 2020-07-06 2020-07-07 0001174891 BUUZ:PromissoryNoteMember BUUZ:BorrowerMember 2020-07-06 2020-07-07 0001174891 BUUZ:PromissoryNoteMember 2022-09-30 0001174891 BUUZ:PromissoryNoteMember 2021-02-19 0001174891 BUUZ:PromissoryNoteMember 2021-02-18 2021-02-19 0001174891 BUUZ:PromissoryNoteOneMember 2021-04-22 0001174891 BUUZ:PromissoryNoteOneMember 2021-04-20 2021-04-22 0001174891 BUUZ:PromissoryNoteOneMember 2022-09-30 0001174891 BUUZ:PromissoryNoteTwoMember 2021-07-02 0001174891 BUUZ:PromissoryNoteTwoMember 2021-06-29 2021-07-02 0001174891 BUUZ:PromissoryNoteTwoMember 2022-09-30 0001174891 BUUZ:PromissoryNoteMember 2022-07-01 2022-09-30 0001174891 BUUZ:PromissoryNoteMember 2022-01-01 2022-09-30 0001174891 BUUZ:PromissoryNoteMember 2021-07-01 2021-09-30 0001174891 BUUZ:PromissoryNoteMember 2021-01-01 2021-09-30 0001174891 BUUZ:ConvertiblePromissoryNoteOneMember 2021-12-31 0001174891 BUUZ:ConvertiblePromissoryNoteTwoMember 2021-12-31 0001174891 BUUZ:ConvertiblePromissoryNoteTwoMember 2021-01-01 2021-12-31 0001174891 BUUZ:ConvertiblePromissoryNoteOneMember 2021-01-01 2021-12-31 0001174891 us-gaap:WarrantMember 2021-12-31 0001174891 us-gaap:WarrantMember srt:MinimumMember 2021-12-31 0001174891 us-gaap:WarrantMember srt:MaximumMember 2021-12-31 0001174891 us-gaap:WarrantMember 2021-01-01 2021-12-31 0001174891 us-gaap:ConvertibleNotesPayableMember 2022-09-30 0001174891 us-gaap:ConvertibleNotesPayableMember 2021-09-30 0001174891 us-gaap:ConvertibleNotesPayableMember 2021-12-31 0001174891 us-gaap:ConvertibleNotesPayableMember 2020-12-31 0001174891 us-gaap:ConvertibleNotesPayableMember 2022-01-01 2022-09-30 0001174891 us-gaap:ConvertibleNotesPayableMember 2021-01-01 2021-12-31 0001174891 srt:MinimumMember 2022-09-30 0001174891 srt:MaximumMember 2022-09-30 0001174891 srt:MinimumMember 2021-12-31 0001174891 srt:MaximumMember 2021-12-31 0001174891 2022-01-02 2022-01-03 0001174891 2022-06-09 0001174891 BUUZ:ConsultantsMember 2021-08-16 2021-08-17 0001174891 srt:ChiefExecutiveOfficerMember 2021-08-16 2021-08-17 0001174891 BUUZ:HyuncheolPeterKimMember 2022-01-01 2022-09-30 0001174891 BUUZ:M1AdvisorsLLCMember 2022-01-01 2022-09-30 0001174891 us-gaap:WarrantMember 2022-01-01 2022-09-30 0001174891 us-gaap:RestrictedStockMember 2022-06-30 0001174891 us-gaap:RestrictedStockUnitsRSUMember BUUZ:TwoThousandTwentyTwoAccretionExpenseMember 2022-07-01 2022-09-30 0001174891 us-gaap:RestrictedStockUnitsRSUMember BUUZ:TwoThousandTwentyTwoAccretionExpenseMember 2022-01-01 2022-09-30 0001174891 us-gaap:RestrictedStockUnitsRSUMember BUUZ:ReversalTwoThousandTwentyOneAccretionExpenseMember 2022-07-01 2022-09-30 0001174891 us-gaap:RestrictedStockUnitsRSUMember BUUZ:ReversalTwoThousandTwentyOneAccretionExpenseMember 2022-01-01 2022-09-30 0001174891 us-gaap:RestrictedStockUnitsRSUMember BUUZ:ReversalTwoThousandTwentyTwoAccretionExpenseMember 2022-07-01 2022-09-30 0001174891 us-gaap:RestrictedStockUnitsRSUMember BUUZ:ReversalTwoThousandTwentyTwoAccretionExpenseMember 2022-01-01 2022-09-30 0001174891 us-gaap:RestrictedStockUnitsRSUMember 2022-07-01 2022-09-30 0001174891 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-09-30 0001174891 us-gaap:WarrantMember 2021-07-01 2021-09-30 0001174891 us-gaap:WarrantMember 2021-01-01 2021-09-30 0001174891 BUUZ:ConvertibleNotesMember 2021-01-01 2021-09-30 0001174891 BUUZ:RestrictedStockUnitsMember 2021-01-01 2021-09-30 0001174891 us-gaap:WarrantMember 2022-07-01 2022-09-30 0001174891 us-gaap:WarrantMember 2022-01-01 2022-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:KRW

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
   
  For the quarterly period ended September 30, 2022
   
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
   
  For the transition period from __________ to __________

 

Commission File No. 000-50331

 

CalEthos, Inc.

(Exact name of registrant as specified in its charter)

 

Nevada   98-0371433

(State or other jurisdiction

of incorporation or organization)

 

(I.R.S. Employer

Identification No.)

     

11753 Willard Avenue

Tustin, California

  92782
(Address of Principal Executive Offices)   (Zip Code)

 

(714) 352-5315

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes ☐ No

 

As of November 3, 2022, there were 14,495,621 outstanding shares of the registrant’s common stock, par value $0.001 per share.

 

 

 

 
 

 

TABLE OF CONTENTS

 

    PAGE
Cautionary Note Regarding Forward Looking Statements iii
     
PART I FINANCIAL INFORMATION  
Item 1. Financial Statements (unaudited)  
  Condensed Consolidated Balance Sheets as of September 30, 2022 (unaudited) and December 31, 2021 1
  Unaudited Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2022 and 2021 2
  Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Deficit for the Each of the three quarters ended September 30, 2022 and 2021 3
  Unaudited Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2022 and 2021 4
  Notes to the Unaudited Condensed Consolidated Financial Statements 5
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 12
Item 3. Quantitative and Qualitative Disclosures about Market Risk 15
Item 4. Controls and Procedures 15
     
PART II OTHER INFORMATION  
Item 1. Legal Proceedings 16
Item 1A. Risk Factors 16
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 16
Item 3. Default Upon Senior Securities 16
Item 4. Mine Safety Disclosures 16
Item 5. Other Information 16
Item 6. Exhibits 16
  Signatures 17

 

-i-
 

 

PART I - FINANCIAL INFORMATION

 

Item 1: Financial Statements

 

CalEthos, Inc.

For the Nine Months Ended September 30, 2022

 

Index to the Condensed Consolidated Financial Statements

 

Contents Page (s)
   
Condensed Consolidated Balance Sheets as of September 30, 2022 (unaudited) and December 31, 2021 1
   
Unaudited Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2022 and 2021 2
   
Unaudited Condensed Consolidated Statements of Stockholders’ Deficit for each of the three quarters ended September 30, 2022 and 2021 3
   
Unaudited Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2022 and 2021 4
   
Notes to the Unaudited Condensed Consolidated Financial Statements 5

 

-ii-
 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

Certain information set forth in this Quarterly Report on Form 10-Q, including in Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere herein, may address or relate to future events and expectations and, as such, constitutes “forward-looking statements” within the meaning of the Private Securities Litigation Act of 1995. Statements which are not historical reflect our current expectations and projections about our future results, performance, liquidity, financial condition, prospects and opportunities and are based upon information currently available to us and our management and their interpretation of what is believed to be significant factors affecting our business, including many assumptions regarding future events. Such forward-looking statements include statements regarding, among other things:

 

  our ability to implement our current stated business plans;
     
  our ability to retain key members of our management team;
     
  our future financing or acquisition plans and our ability to consummate any such transactions on favorable terms if at all;
     
  our anticipated needs for working capital; and
     
  our ability to establish a market for our common stock and operate as a public company.

 

Forward-looking statements, which involve assumptions and describe our future plans, strategies, and expectations, are generally identifiable by use of the words “may,” “should,” “would,” “could,” “scheduled,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” “seek,” or “project” or the negative of these words or other variations on these words or comparable terminology. Actual results, performance, liquidity, financial condition and results of operations, prospects and opportunities could differ materially and perhaps substantially from those expressed in, or implied by, these forward-looking statements as a result of various risks, uncertainties and other factors.

 

Readers should not place undue reliance on any forward-looking statements. Except as expressly required by the federal securities laws, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changed circumstances or any other reason.

 

-iii-
 

 

CalEthos, Inc.

Condensed Consolidated Balance Sheets

 

   As of
September 30,
2022
   As of
December 31,
2021
 
    (Unaudited)      
Assets          
Current assets          
Cash and cash equivalents  $2,249,000   $3,047,000 
Prepaid and other current expenses   1,000    7,000 
Total current assets  $2,250,000   $3,054,000 
           
Other assets   -    38,000 
Total assets   2,250,000    3,092,000 
           
Liabilities and stockholders’ deficit          
Current liabilities          
Accounts payable and accrued expenses  $464,000   $434,000 
Convertible promissory notes, net   4,613,000    3,087,000 
Notes payable   86,000    111,000 
Total current liabilities   5,163,000    3,632,000 
           
Stockholders’ deficit          
Series A convertible preferred stock, par value $0.001, 3,600,000 shares authorized; no shares issued and outstanding   -    - 
Preferred stock, par value $0.001, 100,000,000 shares authorized; no shares issued and outstanding   -    - 
Common stock par value $0.001: 100,000,000 shares authorized; 14,495,621 and 25,995,621 shares issued and outstanding   15,000    26,000 
Additional paid-in capital   11,488,000    16,269,000 
Other comprehensive loss   17,000    (2,000)
Stock subscription receivable   (2,000)   (2,000)
Accumulated deficit   (14,431,000)   (16,831,000)
Total stockholders’ deficit   (2,913,000)   (540,000)
           
Total liabilities and stockholders’ deficit  $2,250,000   $3,092,000 

 

See accompanying notes to these Unaudited Condensed Consolidated Financial Statements.

 

1
 

 

CalEthos, Inc.

Unaudited Condensed Consolidated Statements of Operations

 

   2022   2021   2022   2021 
   For the three months ended
September 30,
   For the nine months ended
September 30,
 
   2022   2021   2022   2021 
Revenues  $-   $-   $-    $- 
                     
Operating Expenses                    
Professional fees   136,000    118,000    558,000    824,000 
Restricted stock grants   (11,168,000)   1,745,000    (4,791,000)   1,745,000 
General and administrative expenses   24,000    13,000    59,000    18,000 
Impairment loss   -    -    154,000    - 
Operating (income) expenses   (11,008,000)   1,876,000    (4,020,000)   2,587,000 
                     
Income(loss) from operations   11,008,000    (1,876,000)   4,020,000    (2,587,000)
                     
Other income (expenses)                    
Interest income   1,000    -    1,000    - 
Financing costs   (509,000)   (187,000)   (1,622,000)   (226,000)
Total other expense   (508,000)   (187,000)   (1,621,000)   (226,000)
                     
Income (loss) before provision for income taxes   10,500,000    (2,063,000)   2,399,000    (2,813,000)
Provision for income taxes   -    -    -    - 
                     
Net income (loss)  $10,500,000   $(2,063,000)  $2,399,000   $(2,813,000)
                     
Net income (loss) per share - basic  $0.74   $(0.12)  $0.10   $(0.16)
Net income (loss) per share - diluted  $

0.56

   $

(0.12

)  $

0.08

   $

(0.16

)
                     
Weighted average common shares outstanding - Basic   14,176,349    17,602,886    24,769,518    17,282,889 
Weighted average common shares outstanding - diluted   

18,953,625

    

17,602,886

    

29,546,794

    

17,282,889

 
                     
Comprehensive loss:                    
Net income (loss)  $10,500,000   $(2,063,000)  $2,399,000   $(2,813,000)
Foreign currency translation adjustment   20,000    -    19,000    - 
Comprehensive income (loss)  $10,520,000   $(2,063,000)   2,418,000   $(2,813,000)

 

See accompanying notes to these Unaudited Condensed Consolidated Financial Statements.

 

2
 

 

CalEthos, Inc.

Unaudited Condensed Consolidated Statements of Stockholders’ Deficit

For the Nine Months Ended September 30, 2022

 

   Shares   Loss   Shares   Amount   Shares   Amount   Capital   Receivable   Loss   Deficit   Deficit 
   Series A convertible preferred stock   Preferred Stock   Common Stock   Additional Paid-in   Stock Subscription   Other Comprehensive    Accumulated   Total Stockholders Equity 
   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Receivable   Income (Loss)   Deficit   (Deficit) 
                                             
Balance, January 1, 2022   -   $-    -   $-    25,995,621   $26,000   $16,269,000   $(2,000)  $(2,000)  $(16,831,000)  $(540,000)
Restricted stock grants   -    -    -    -    -    -    3,170,000    -    -    -    3,170,000 
Forgein currency translation income (loss)   -    -    -    -    -    -    -    -    (3,000)   -    (3,000)
Net loss   -    -    -    -    -    -    -    -    -    (3,926,000)   (3,926,000)
Balance, March 31, 2022   -    -    -    -    25,995,621    26,000    19,439,000    (2,000)   (5,000)   (20,757,000)   (1,299,000)
Restricted stock grants   -    -    -    -    -    -    3,206,000                   3,206,000 
Forgein currency translation income (loss)   -    -    -    -    -    -    -    -    2,000         2,000 
Net loss   -    -    -    -    -    -    -    -    -    (4,174,000)   (4,174,000)
Balance, June 30, 2022   -    -    -    -    25,995,621    26,000    22,645,000    (2,000)   (3,000)   (24,931,000)   (2,265,000)
Forfeiture of stock-based compensation                       (11,500,000)   (11,000)   (11,157,000)                  (11,168,000)
Forgein currency translation income (loss)   -    -    -    -    -    -    -    -    20,000         20,000 
Net loss   -    -    -    -    -    -    -    -    -    10,500,000    10,500,000 
Balance, Sep 30, 2022   -   $-    -   $-    14,495,621   $15,000   $11,488,000   $(2,000)  $17,000   $(14,431,000)  $(2,913,000)

 

For the Nine Months Ended September 30, 2021

 

   Series A convertible preferred stock   Preferred Stock   Common Stock   Additional Paid-in   Stock Subscription   Other Comprehensive    Accumulated   Total Stockholders Equity 
   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Receivable   Income (Loss)   Deficit   (Deficit) 
Balance, January 1, 2021   -   $-    -   $-    16,634,951   $17,000   $8,744,000   $(2,000)  $-   $(10,082,000)  $(1,323,000)
Relative fair value of warrants issued with convertible promissory notes   -    -    -    -    -    -    3,000    -    -    -    3,000 
Stock options issued for services   -    -    -    -    -    -    52,000    -    -    -    52,000 
Stocks issued from debt forgiveness   -    -    -    -    75,000    -    98,000    -    -    -    98,000 
Additional capital from debt forgiveness   -    -    -    -    -    -    68,000    -    -         68,000 
Net Loss   -    -    -    -    -    -    -    -    -    (92,000)   (92,000)
Balance, March 31, 2021   -    -    -    -    16,709,951    17,000    8,965,000    (2,000)   -    (10,174,000)   (1,194,000)
Stocks returned   -    -    -    -    (3,674,330)   (4,000)   4,000              -    - 
Stock options issued for services   -    -    -    -              561,000         -    -    561,000 
Stock issued on exercise of warrants   -    -    -    -    1,435,000    2,000         -    -    -    2,000 
Net loss   -    -    -    -                             (658,000)   (658,000)
Balance June 30, 2021   -    -    -    -    14,470,621    15,000    9,530,000    (2,000)   -    (10,832,000)   (1,289,000)
Relative fair value of warrants issued with convertible promissory notes        -              -         1,687,000    -         -    1,687,000 
Stock-based compensation                  -              195,000         -         195,000 
Restricted stock grants                       11,500,000    11,000    1,539,000    -         -    1,550,000 
Net loss             -              -         -    -    (2,063,000)   (2,063,000)
Balance September 30, 2021   -   $-    -   $-    25,970,621   $26,000   $12,951,000   $(2,000)  $-   $(12,895,000)  $80,000 

 

See accompanying notes to these Unaudited Condensed Consolidated Financial Statements.

 

3
 

 

CalEthos, Inc.

Unaudited Condensed Consolidated Statements of Cash Flows

 

    1    2 
   For the nine months ended
September 30,
 
   2022   2021 
Cash Flows From Operating Activities          
Net loss  $2,399,000   $(2,813,000)
Adjustments to reconcile net loss to net cash used in operating activities:          
Impairment   154,000    - 
Amortization of convertible promissory note discounts   1,526,000    172,000 
Fair value of equity-based compensation   -    770,000 
Forfeiture of restricted stock grants   (11,168,000)   - 
Accretion of compensation cost for restricted stock awards   6,377,000    1,550,000 
Changes in operating assets and liabilities          
Prepaid expenses and other current assets   6,000    2,000 
Accounts payable and accrued expenses   32,000    18,000 
Net Cash Used in Operating Activities   (674,000)   (301,000)
           
Cash Flows From Investing Activities          
Other assets   (106,000)   - 
Net Cash Used in Investing Activities   (106,000)   - 
           
Cash Flows From Financing Activities          
Proceeds from the issuance of convertible promissory notes   -    3,550,000 
Proceeds from the issuance of notes payable   -    128,000 
Repayments of Notes   (25,000)   - 
Net Cash (Used in) Provided by Financing Activities   (25,000)   3,678,000 
           
Effect of exchange rate changes on cash and cash equivalents   7,000    - 
Net increase (decrease) in Cash   (798,000)   3,377,000 
Cash, Beginning of Period   3,047,000    - 
Cash, End of Period  $2,249,000   $3,377,000 
           
Supplemental disclosure of cash flow information:          
Cash paid for interest  $-   $- 
Cash paid for income taxes  $-   $- 
           
Non-cash investing and financing activities          
Relative fair value of warrants issued with convertible promissory notes  $    $3,000
Accrued equity compensation granted  $-   $38,000 
Common stock issued from forgiven debt  $-   $98,000 
Additional capital from forgiven debt  $-   $68,000 

 

See accompanying notes to these Unaudited Condensed Consolidated Financial Statements.

 

4
 

 

CalEthos, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

September 30, 2022

 

Note 1 – Organization and Accounting Policies

 

CalEthos, Inc. (the “Company” or “we”) was incorporated on March 20, 2002 under the laws of the State of Nevada.

 

The Company is implementing its plan to build a clean-energy-powered, containerized, immersion-cooled data center that provides wholesale colocation data center services to enterprise IT and hyperscale customers. In addition, the Company may acquire assets and all or part of other companies operating in the high-density computing industry or to invest or joint venture with other more-established companies already in the industry that would add value to the Company’s business strategy.

 

In July 2022, due to the declining state of the bitcoin mining industry and market for its planned products, the Company’s board of directors resolved to discontinue the development in South Korea of the Company’s 5 nanometer ASIC chip and containerized, immersion-cooled bitcoin mining computer system and to focus exclusively on developing the clean-energy-powered data center segment of its business strategy. The Company has suspended operations of its South Korean subsidiary and will decide in the next twelve months whether to use it to develop other products or dissolve it.

 

Amendments to Certificate of Incorporation

 

In October 2021, the Board of Directors authorized an amendment to the Articles of Incorporation of the Company to change the Company’s name to AIQ Blockchain, Inc. The name change has not yet been effected, and on July 2022, FINRA was notified that the Company was no longer changing its name or symbol and that the application was being withdrawn.

 

Korean entity

 

On November 5, 2021, AIQ System Inc. (“AIQ”) was incorporated in Seoul, Republic of Korea. AIQ is authorized to issue 3 million shares of common stock. At the date of incorporation, 10,000 shares were issued to the Company for 100,000,000 Korean Won or approximately $89,000 for 100% ownership of AIQ.

 

Basis of Presentation

 

The accompanying Condensed Consolidated Financial Statements and notes thereto are unaudited. The unaudited interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and note disclosures normally included in the Company’s annual financial statements have been condensed or omitted. The September 30, 2022 condensed consolidated balance sheet data was derived from audited financial statements but does not include all disclosures required by GAAP. These interim unaudited condensed consolidated financial statements, in the opinion of management, reflect all normal recurring adjustments necessary for a fair presentation of the financial position, results of operations and cash flows for the interim nine-months period ended September 30, 2022 and 2021. The results for the nine months ended September 30, 2022 are not necessarily indicative of the results to be expected for the full year ending December 31, 2022 or for any future period.

 

These unaudited Condensed Consolidated Financial Statements should be read in conjunction with the Company’s audited Consolidated Financial Statements and the notes thereto for the year ended December 31, 2021, included in the Company’s annual report on Form 10-K filed with the SEC on March 31, 2022.

 

5
 

 

Liquidity and Going Concern

 

The Company incurred net income of approximately $2,399,000 for the nine months ended September 30, 2022, of which $4,791,000 was attributable to a non cash transaction for the reversal of compensation for restricted stock units, and had an accumulated deficit of approximately $14,431,000 as of September 30, 2022. The Company has financed its activities principally through debt and equity financing and shareholder contributions. Management expects to incur additional losses and cash outflows in the foreseeable future in connection with its operating activities.

 

The Company’s condensed consolidated financial statements have been presented on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.

 

The Company is subject to a number of risks similar to those of other similar stage companies, including dependence on key individuals; successful development, marketing and branding of products; uncertainty of product development and generation of revenues; dependence on outside sources of financing; risks associated with research and development; dependence on third-party suppliers and collaborators; protection of intellectual property; and competition with larger, better-capitalized companies. Ultimately, the attainment of profitable operations is dependent on future events, including obtaining adequate financing to fund its operations and generating a level of revenues adequate to support the Company’s cost structure.

 

The Company will need to raise debt or equity financing in the future in order to continue its operations and achieve its growth targets. However, there can be no assurance that such financing will be available in sufficient amounts and on acceptable terms, when and if needed, or at all. The precise amount and timing of the funding needs cannot be determined accurately at this time, and will depend on a number of factors, including market demand for the Company’s products and services, the success of product development efforts, the timing of receipts for customer deposits, the management of working capital, and the continuation of normal payment terms and conditions for purchase of goods and services. The Company believes its cash balances and cash flow from operations will not be sufficient to fund its operations and growth for the next twelve months from the issuance date of these financial statements. If the Company is unable to substantially increase revenues, reduce expenditures, or otherwise generate cash flows from operations, then the Company will likely need to raise additional funding from investors or through other avenues to continue as a going concern.

 

COVID-19

 

The continuing COVID-19 global pandemic has caused significant disruption to the economy and financial markets globally, and the full extent of the potential impacts of COVID-19 are not yet known. Circumstances caused by the COVID-19 pandemic are complex, uncertain and rapidly evolving. The impact of COVID-19 has not been significant to the Company’s results of operations, financial condition, and liquidity and capital resources. Although no material impairment or other effects have been identified to date, there is substantial uncertainty in the nature and degree of its continued effects over time. That uncertainty affects management’s accounting estimates and assumptions, which could result in greater variability in a variety of areas that depend on these estimates and assumptions as additional events and information become known. The Company will continue to consider the potential impact of the COVID-19 pandemic on its business operations.

 

Earnings Per Share

 

We use ASC 260, “Earnings Per Share” for calculating the basic and diluted earnings (loss) per share. We compute basic earnings (loss) per share by dividing net income (loss) by the weighted average number of common shares outstanding. Diluted earnings (loss) per share is computed based on the weighted average number of shares of common stock plus the effect of dilutive potential common shares outstanding during the period using the treasury stock method. Dilutive potential common shares include outstanding stock options and warrants and stock awards. For periods with a net loss, basic and diluted loss per share is the same, in that any potential common stock equivalents would have the effect of being anti-dilutive in the computation of net loss per share.

  

6
 

 

Recent Accounting Pronouncements

 

The Company’s management reviewed all recently issued accounting standard updates (“ASU’s”) not yet adopted by the Company and does not believe the future adoptions of any such ASU’s may be expected to cause a material impact on the Company’s condensed consolidated financial condition or the results of its operations.

 

Note 2 – Intangible and Other Assets

 

On December 23, 2021, AIQ entered into a Technology Development Agreement (the “Agreement”) with PICOCEL, Co., Ltd. (the “Contractor” or “PICOCEL”) to develop a FPGA based Bitcoin mining simulation system. The Agreement was expected to be completed within 6 weeks for a total contract price of 198,000,000 Korean Won (“KRW”) or approximately $167,000. Total payments made to PICOCEL as of September 30, 2022 amounted to approximately $69,000. On March 17, 2022, the Company and PICOCEL entered into a mutual agreement to cancel and terminate the Agreement. As of the date of the termination, PICOCEL had completed the first phase of the Agreement upon delivery of the SHA-256 code and FPGA board simulator.

 

On April 5, 2022, AIQ entered into a Technology Development Agreement (the “Agreement”) with NNS, Co., Ltd. (the “Contractor” or “NNS”) to develop a FPGA based Bitcoin mining simulation system. The Agreement was expected to be completed within 9 weeks for a total contract price of 99,000,000 KRW, including 9,000,000 KRW VAT, or approximately $82,000. The payments are scheduled as follows:

 

   Amount 
   USD   KRW 
Within 5 days after signing the contract  $41,000    49,500,000 
Within 5 days after all conditions are met as stated in “Schedule B – Statement of Work”   41,000    49,500,000 
Total  $82,000    99,000,000 

 

Payment of 90,000,000 KRW or approximately $69,000 was made to NNS as of September 30, 2022 which was expensed and included in in the condensed consolidated statement of operations.

 

Impairment

 

During the six months ended June 30, 2022, the Bitcoin market was in a constant decline, and since the ASIC chip being developed by AIQ was planned to be used for Bitcoin mining machines, management believes that there is an impairment indicator as of June 30, 2022. Management plans to discontinue the operations of AIQ subsequent to June 30, 2022 and no more future cash flows are expected from AIQ.

 

Indicators of impairment include significant underperformance relative to historical or projected future operating results, significant changes in our use of the assets or in our business strategy, loss of or changes in customer relationships and significant negative industry or economic trends. When indications of impairment arise for a particular asset or group of assets, we assess the future recoverability of the carrying value of the asset (or asset group) based on an undiscounted cash flow analysis. If the carrying value exceeds projected, net, undiscounted cash flows, an additional analysis is performed to determine the asset’ (or asset group), typically a discounted cashflow analysis, and an impairment charge is recorded for the excess of carrying value over fair value.

 

As of September 30, 2022, intangibles and other assets were fully impaired. Impairment loss amounted to $154,000, inclusive of a $12,000 impairment of prepaid VAT related to the services provided by PICOCEL and NNS.

 

The table below summarizes the impairment loss for the nine months ended September 30, 2022:

   Amount   VAT   Total 
PICOCEL  $69,000   $5,000   $74,000 
NNS   69,000    5,000    74,000 
Total   138,000    10,000    148,000 
Foreign exchange loss   4,000    2,000    6,000 
Impairment loss  $142,000   $12,000   $154,000 

 

Note 3 – Accounts Payable and Accrued Expenses

 

The following table summarizes the Company’s accounts payable and accrued expense balances as of the dates indicated:

 

   September 30,   December 31, 
   2022   2021 
Accounts payable  $251,000   $221,000 
Accrued expenses   2,000    99,000 
Accrued interest   211,000    114,000 
Accounts payable and accrued expenses  $464,000   $434,000 

 

Accrued Interest

 

The following table presents the details of accrued interest as of the dates indicated:

 

   September 30,   December 31, 
   2022   2021 
Notes payable  $18,000   $9,000 
Convertible promissory notes   193,000    105,000 
Balance, end of the year  $211,000   $114,000 

 

Note 4 – Notes Payable

  

The table below summarizes the transactions as of the dates indicated:

 

   September 30,   December 31, 
   2022   2021 
Balance, beginning of the year  $111,000   $11,000 
Additions       150,000 
Payments   (25,000)   (50,000)
Balance, end of the year  $86,000   $111,000 

 

7
 

 

On July 7, 2020, the Company issued a promissory note in the principal amount of $11,000. The note is noninterest bearing. The principal was due on or before March 11, 2022. During any event of default under the note, the interest rate shall increase to 10% per annum. Events of default include failure to pay principal or interest, breach of covenants, breach of representations and warranties, borrower’s assignment of substantial part of its property or business, any money judgment, writ, or similar process shall be entered or filed against the borrower or any subsidiary of the borrower or any of its properties or other assets for more than $100,000, bankruptcy, liquidation of business, and cessation of operations. The principal amount outstanding under this note was $11,000 as of September 30, 2022. The note principal and interest are past due, therefore in default. For the nine months ended September 30, 2022 the Company has accrued approximately $2,000 of default interest.

 

On February 19, 2021, the Company issued a promissory note in the principal amount of $25,000. The interest on the unpaid principal balance accrued at a rate of 10% per annum. The principal and any accrued interest was to be paid in a single installment on or before February 19, 2022. If the Company fails to pay the balance of this note in full on the due date or fails to make any payment due within 15 days of the due date, any unpaid principal shall accrue interest at the rate of 15% per annum during the default (default interest). Events of default include failure to make any payment including accrued interest when due, voluntary, or involuntary petition of bankruptcy, appointment of a receiver, custodian, trustee or similar party to take possession of the Company’s assets or property, or assignment made by the Company for the benefit of creditors. The principal amount was settled in full on January 25, 2022.

 

On April 22, 2021, the Company issued a promissory note in the principal amount of $50,000. The interest on the unpaid principal balance accrued at a rate of 10% per annum. The principal and any accrued interest was to be paid in a single installment on or before April 22, 2022. If the Company fails to pay the balance of this note in full on the date or fails to make any payments due within 15 days of the due date, any unpaid principal shall accrue interest at the rate of 15% per annum during the default. Events of default include failure to make any payment including accrued interest when due, voluntary, or involuntary petition of bankruptcy, appointment of a receiver, custodian, trustee or similar party to take possession of the Company’s assets or property, or assignment made by the Company for the benefit of creditors. The principal amount outstanding under this note was $50,000 as of September 30, 2022. The note principal and interest are past due, therefore in default. Interest accrued, including default interest, as of September 30, 2022 is $8,000.

 

On July 1, 2021, the Company issued a promissory note in the principal amount of $25,000. The interest on the unpaid principal balance accrues at a rate of 10% per annum. The principal and any accrued interest was to be paid in a single installment on or before July 1, 2022. If the Company fails to pay the balance of this note in full on the date or fails to make any payments due within 15 days of the due date, any unpaid principal shall accrue interest at the rate of 15% per annum during the default (default interest). Events of default include failure to make any payment including accrued interest when due, voluntary, or involuntary petition of bankruptcy, appointment of a receiver, custodian, trustee or similar party to take possession of the Company’s assets or property, or assignment made by the Company for the benefit of creditors. The principal amount outstanding under this note was $25,000 as of September 30, 2022. The note principal and interest are past due, therefore in default. Interest accrued, including default interest, as of September 30, 2022 is $3,000.

 

Interest expense on notes payable amounted to $3,000 and $9,000 for the three and nine months ended September 30, 2022, respectively, and $4,000 and $8,000 for the three and nine months ended September 30, 2021, respectively.

 

8
 

 

Note 5 – Convertible Promissory Notes

 

In 2021, the Company issued two convertible promissory notes amounting to $55,000 and $3,850,000 (the “Notes”), respectively. The total aggregate proceeds were $3,550,000 due to a $355,000 aggregate original issue discount. The Notes are non-interest bearing with the principal due and payable on March 1, 2022 and August 31, 2022, respectively. Any amount of unpaid principal on the date of maturity will accrue interest at rate of 10% per annum (default interest). Interest accrued as of September 30, 2022 is $35,000. The principal amount and all accrued interest are convertible into shares of the Company’s common stock, as of the date of issuance, at a rate of $1.00 and $1.25 per share (“Conversion Rate”), respectively. The Conversion Rate is adjustable if, at any time when any principal amount of the Notes remains unpaid or unconverted, the Company issues or sells any shares of the Company’s common stock for no consideration or for a consideration per share (before deduction of reasonable expenses or commissions or underwriting discounts or allowances in connection therewith), which is less than the Conversion Rate in effect on the date of such issuance (or deemed issuance) of such shares of common stock (a “Dilutive Issuance”). Immediately upon a Dilutive Issuance, the Conversion Rate will be reduced to the amount of the consideration per share received by the Company in such Dilutive Issuance. Events of default include failure to issue conversion shares, the occurrence of a breach or default under any other agreement, any money judgment, writ, or similar process entered or filed against the Company or any of its property or other assets for more than $100,000, bankruptcy filing, application for the appointment of a custodian, trustee or receiver, insolvency, the Company’s common stock delisted, or dissolution, winding up, or termination of the business of the Company. The note principal and interest are past due, therefore in default.

 

In connection with the issuance of the Notes, the Company issued to the purchasers of the Notes stock purchase warrants (the “Warrants”) to purchase an aggregate of 1,567,500 shares of the Company’s common stock for a purchase price of $1.50 to $1.87 per share, subject to adjustments. The Warrants were valued using the Black Scholes option pricing model for a total fair value of $3,004,000 based on a 3-year term, volatility of 404.91% to 405.93%, a risk-free equivalent yield of 0.27% to 0.42%, and stock price ranging from $0.10 to $1.95.

 

In accordance with ASC 470 - Debt, the Company has allocated the cash proceeds amounts of the Notes among the Notes, the Warrants and the conversion feature. The relative fair value of the Warrants issued amounted to approximately $1,690,000 and the beneficial conversion amounted to $0, which amounts are being amortized and expensed over the term of the Notes.

 

The Company determined that the conversion feature of the Notes would not be an embedded feature to be bifurcated and accounted for as a derivative in accordance with ASC 815-15 Derivatives and Hedging.

 

Financing cost recognized for the amortization of debt discount was approximately $1,526,000 and $170,000 for the nine months ended September 30, 2022 and 2021, respectively.

 

The convertible promissory notes consisted of the following as of the dates indicated:

 

   September 30,   December 31, 
   2022   2021 
Principal          
Balance, beginning of year  $4,613,000   $708,000 
Additions       3,905,000 
Balance, end of period   4,613,000    4,613,000 
           
Discount          
Balance, beginning of year   1,526,000    5,000 
Additions       2,045,000 
Amortization   (1,526,000)   (524,000)
Balance, end of period   -    1,526,000 
Net carrying amount  $4,613,000   $3,087,000 

 

9
 

 

Effective interest rate used to amortize the debt discount for the nine months ended September 30, 2022 and 2021 ranges from 4.76% to 64.60%.

 

Potential future shares to be issued on conversion of the notes as of the dates indicated are as follows:

 

   September 30,   December 31, 
   2022   2021 
Principal  $4,613,000   $4,613,000 
Interest   193,000    105,000 
Total   4,806,000    4,718,000 
Conversion price per share   1.00 1.25    1.001.25 
Potential future share   4,028,844    3,947,394 

 

The default interest expense for the convertible promissory notes amounted to $88,000 and $48,000 for the nine months ended September 30, 2022 and 2021, respectively.

 

Note 6 – Commitments and contingencies

 

Litigation

 

From time to time, the Company may become subject to legal proceedings, claims and litigation arising in the ordinary course of business. In addition, the Company may receive letters alleging infringement of patent or other intellectual property rights. The Company is not currently a party to any material legal proceedings, nor is the Company aware of any pending or threatened litigation that would have a material adverse effect on the Company’s business, operating results, cash flows or financial condition should such litigation be resolved unfavorably, except as follows.

 

On January 3, 2022, a complaint was filed against our company in the Superior Court of California, County of Los Angeles titled Michael Sekula v. CalEthos Inc, Michael Campbell and Does 1-25 (Case No. 22STCV00121) for, among other matters, failure to pay wages, fraud and other wage-related claims. In the complaint, the plaintiff claimed he worked under a consulting agreement as Vice President of Brand Management of our company and was to be paid $4,000 per month and to receive an option to purchase 50,000 shares of our common stock that was to vest quarterly over the term of the agreement. In the complaint, the plaintiff alleged that, on or around March 27, 2020, the Company ceased paying the plaintiff despite the plaintiff’s continuing efforts on behalf of our company and that the Company agreed to continue to accrue his monthly retainer amount until such time that the Company received at least $100,000 in funding. Plaintiff further alleged that he continued to work for our company for 38 additional weeks in reliance on our promise of payment. The plaintiff claimed that our refusal to make the promised payments amounts to violations of the California labor laws and seeks damages in excess of $450,000.

 

On June 9, 2022, a Settlement Agreement and Mutual Release was reached by the parties whereby as full consideration for the plaintiff’s execution of and compliance with the agreement and plaintiff’s release of all claims against the defendants, the Company agreed to pay a gross settlement amount of $90,000. Such payment was made on June 23, 2022.

 

Note 7 – Stockholders Deficit

 

Restricted Common Stock Awards

 

On August 17, 2021, the Company entered into Restricted Share Award Agreements (the “Award Agreements”) with two consultants pursuant to which the Company issued to the consultants shares of common stock of the Company in exchange for their future services. The Awards had an initial term of one year, which was to be automatically renewed on a year-to-year basis unless either party gave a written notice of termination. The two consultants who entered into these agreements include:

 

  1) A consultant who was granted 10,000,000 restricted share awards.
  2) An entity, which is owned by the Company’s CEO and majority shareholder, was granted 1,500,000 restricted share awards.

 

The Company’s management accounted for the Award Grants as restricted stock compensation in accordance with ASC 718 – Stock Compensation (“ASC 718”). ASC 718 required the Company to estimate the service period over which the compensation cost would be recognized. Management had estimated that the first two development phases would be completed within 15 months and the Foundry Mask would be completed within 6 months for a total of 21 months service period. Compensation cost was to be recognized ratably over 21 months and in the same manner had the Company paid in cash. The estimated service period would be adjusted for changes in actual and expected completion dates. Any such change was to be recognized prospectively, and the remaining deferred compensation was to be recognized over the remaining service period.

 

10
 

 

The Company issued restricted stock grants totaling 10,000,000 shares to Hyuncheol (Peter) Kim, the Company’s former Chief Technology Officer, and 1,500,000 to a M1 Advisors LLC, a company owned by the Company’s chief executive officer. The value was $1.93 per share on the date of issuance (“Grant Date”) for an aggregate fair value of $22,195,000

 

The stock-based award compensation was recorded as an increase in deferred compensation expense, common stock, and additional paid-in capital in the Company’s books at the time of the grant.

 

On July 27, 2022, the Company sent Hyuncheol (Peter) Kim, the Company’s former Chief Technology Officer, a letter notifying him that the Company’s Board of Directors had resolved to discontinue the Company’s 5 nanometer ASIC chip and bitcoin mining machine project and that his consulting agreement will terminate at the end of August 2022. The restricted stock grant issued in connection with the consulting agreement will also be cancelled.

 

Also, at the end of August 2022, the Company cancelled the restricted stock grant issued to M1 Advisors LLC.

 

The table below summarizes the transactions related to the Company restricted stock awards as of September 30, 2022:

 

   Shares   Deferred
compensation
 
Grant date fair value   11,500,000   $22,195,000 
Accretion   -    (11,168,000)
Forfeiture   (11,500,000)   (11,027,000)
Balance as of September 30, 2022   -   $- 

 

Restricted stock grant compensation expense for the three and nine months ended September 30, 2022, is as follows:

  

   Three months
ended
   Nine months
ended
 
   September 30,
2022
   September 30,
2022
 
2022 Accretion expense  $-   $6,377,000 
Reversal of 2021 accretion expense   (4,791,000)   (4,791,000)
Reversal of 2022 accretion expense   (6,377,000)   (6,377,000)
Restricted stock grant compensation  $(11,168,000)  $(4,791,000)

 

Warrants Expired

 

As of September 30, 2022, a total of 253,000 warrants expired.

 

Note 8 – Earnings (Loss) Per Share

 

The following table sets forth the computation of basic and diluted earnings (loss) per share

 

Numerator  2022   2021   2022   2021 
   For the three Months Ended September 30,   For the Nine Months Ended September 30, 
Numerator  2022   2021   2022   2021 
Net income (loss)  $10,500,000   $(2,063,000)  $2,399,000   $(2,813,000)
Effect of dilutive instruments                    
Convertible notes interest expense   51,000    -    88,000    - 
Numerator for diluted EPS   10,551,000    (2,063,000)   2,487,000    (2,813,000)
                     
Denominator                    
Denominator - for basic EPS   14,176,349    17,602,886    24,769,518    17,282,889 
                     
Effect of dilutive instruments                    
Warrants   748,432    -    748,432    - 
Convertible notes   4,028,844    -    4,028,844    - 
Dilutive potential common shares   4,777,276    -    4,777,276    - 
                     
Denominator for diluted EPS   18,953,625    17,602,886    29,546,794    17,282,889 
                     
Basic EPS  $0.74   $(0.12)  $0.10   $(0.16)
Diluted EPS  $0.56   $(0.12)  $0.08   $(0.16)

 

Securities that could potentially dilute loss per share in the future were not included in the computation of diluted loss per share for the three and nine months ended September 30, 2021 because their inclusion would be anti-dilutive. Common share equivalents amounted to 3,942,608 for warrants, 4,612,607 for convertible notes and 11,500,000 for restricted stock units for total of 20,055,215 as of September 30, 2021. For the three and nine months ended September 30, 2022, the Company had 4,777,276 dilutive securities.

 

Note 9 – Subsequent Events

 

The Company has evaluated all events that occurred after the balance sheet date through the date when the financial statements were issued to determine if they must be reported. The management of the Company determined there are no reportable events.

 

11
 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The following discussion should be read in conjunction with our financial statements and related notes thereto included elsewhere in this Quarterly Report on Form 10-Q and the financial statements and related notes thereto in our Annual Report on Form 10-K for the year ended December 31, 2021.

 

This discussion contains certain forward-looking statements that involve risks and uncertainties. Our actual results and the timing of certain events could differ materially from those discussed in these forward-looking statements as a result of certain factors, including, but not limited to, those set forth herein and elsewhere in this Quarterly Report and in our other filings with the Securities and Exchange Commission. See “Cautionary Note Regarding Forward Looking Statements.”

 

Plan of Operations

 

As of the filing of this Report, it is our plan to continue our focus on building a large-scale, clean-energy powered, containerized, immersion-cooled data center operation that will provide wholesale colocation services to high-density computing, enterprise customers. While it was originally part of our strategy to build such a facility for our own utilization with the bitcoin mining systems that we planned to manufacture and use for our own bitcoin mining operations, going forward, our operating plan is to focus only on developing and building clean-energy powered, containerized, immersion-cooled data centers for enterprise customers. To implement this plan, we intend to complete the purchase of 80 acres of land and to negotiate a Power Purchase Agreement with the local utility company for up to 100 megawatts of clean energy from local geothermal power plants and solar farms and to evaluate various paths for accessing close-by fiber networks.

 

Once the land acquisition is closed, we intend to complete a land use plan that will be submitted to authorities for approval and for permits to start construction. We expect, based on all related factors, that a submittable plan, which will include civil engineering, data center and infrastructure design and construction schedule will take approximately three months to complete. Once submitted to the appropriate governmental departments and agencies for approval, it is expected that it could take another three months or more before we receive the required permits for construction, and that the construction could take another six months or more to complete depending on supply chain issues at the time for data center, electrical and communication connectivity components of the data center build.

 

As we move through the development process to build a clean-energy powered, containerized, immersion-cooled data center, we will continue to refine and finalize the courses of action needed to implement our business plan and operations. As a result, management has not fully determined our actual short-term or long-term capital requirements, which management expects to be substantial.

 

It is anticipated that we will incur significant expenses in the implementation of our business plan as described herein, and that we will require substantial financing to complete the development and construction of the planned data center operation. A failure to obtain this necessary capital when required on acceptable terms, or at all, could force us to delay, limit, reduce or terminate our development plans, any commercialization efforts and any other operations. We may not be able to secure financing on favorable terms, or at all, to meet our future capital needs. In addition, even if we are able to obtain sufficient funding to commence our business operations, we may need to pursue additional financing in the future to make expenditures and/or investments to support the growth of our business. In addition, we may require additional capital to pursue our business objectives and respond to new competitive pressures, pay extraordinary expenses or fund our growth, including through acquisitions. Additional funding, however, may not be available when required on terms that are acceptable to us, or at all. If we are unable to obtain adequate financing or financing on terms satisfactory to us when it is required, our ability to commence and grow our proposed business operations, to support our business and to respond to business challenges could be significantly limited.

 

We currently have only limited capital with which to pay these anticipated expenses. To fund our business plan going forward, we intend to raise funds from investors by issuing common stock, preferred stock and/or debt securities.

 

12
 

 

Results of Operations

 

The table summarizes the results of operations for the three and six months ended June 30:

 

  

For the Three Months Ended

September 30,

  

For the Nine Months Ended

September 30,

 
   2022   2021   2022   2021 
                 
Revenues  $-   $-   $-   $- 
Operating expenses                    
Professional fees   136,000    118,000    588,000    824,000 
Stock based compensation   (11,168,000)   1,745,000    (4,791,000)   1,745,000 
General and administrative expenses   24,000    13,000    59,000    18,000 
Impairment loss   -    -    154,000    - 
Total operating (income)expenses   (11,008,000)   1,876,000    (4,020,000)   2,587,000 
Income (loss) from operations   11,008,000    (1,876,000)   4,020,000    (2,587,000)
                     
Other income (expense)                    
Interest income   1,000    -    1,000    - 
Financing costs   (509,000)   (187,000)   (1,622,000)   (226,000)
Total other expenses   (508,000)   (187,000)   (1,621,000)   (226,000)
                     
Income (loss) before provision for income taxes   10,500,000    (2,063,000)   2,399,000    (2,813,000)
Provision for income taxes   -    -    -    - 
Net income (loss)  $10,500,000   $(2,063,000)  $2,399,000   $(2,813,000)

 

Revenues

 

The Company had no revenues for the nine months ended September 30, 2022 and 2021.

 

Expenses

 

Operating (income) expense for the nine months ended September 30, 2022 was $4,020,000, compared to $(2,587,000) for the nine months ended September 30, 2021. The increase of $6,607,000, in operating income, pertains primarily to (1) reversal of $4,791,000 of stock-based compensation expense, for the year ended December 31, 2021, related to the forfeiture of the stock-based awards. Since the Company discontinued the development in South Korea of the Company’s 5 nanometer ASIC chip and containerized, immersion-cooled bitcoin mining computer system, management determine that performance-based service would not be achievable. Also, the stock-based compensation for the nine months ended September 31, 2022 was nil, because of the reversal of unvested restricted stock awards, which was forfeited, compared to the stock based compensation expense of $1,745,000 for the nine months ended September 31, 2021. The expense of $90,000 for settling a legal case for the nine months ended September 30, 2022.

 

Liquidity and Capital Resources

 

The Company’s financial position as of September 30, 2022 and December 31, 2021 were as follows:

 

Working Deficit

 

   September 30,
2022
   December 31,
2021
 
   (Unaudited)     
Current assets  $2,250,000   $3,054,000 
Current liabilities   5,163,000    3,632,000 
Working deficit  $(2,913,000)  $(578,000)

 

At September 30, 2022, the Company had cash of approximately $2,249,000 and prepaid expenses of approximately $1,000. The working deficit increased by approximately $2,335,000 from December 31, 2021 to September 30, 2022. The increase in the working capital deficit was due primarily to the decrease in cash of $798,000 and the increase in convertible promissory of approximately $1,526,000.

 

At September 30, 2022, the Company had outstanding promissory notes and accrued interest in the aggregate amount of $104,000 and outstanding convertible notes and accrued interest in aggregate amount of $4,806,000, all of which were past due and all of which were in default. See Notes 4 and 5 to the accompanying unaudited financial statements of the Company.

 

Cash Flows

 

   For the Nine Months Ended
September 30,
 
   2022   2021 
         
Net cash used in operating activities  $(674,000)  $(301,000)
Net cash used in investing activities   (106,000)   - 
Net cash provided by (used in) financing activities   (25,000)   3,678,000 
Effect of exchange rate changes   7,000    - 
Increase (decrease) in Cash during the Period   (798,000)   3,377,000 
Cash, Beginning of Period   3,047,000    - 
Cash, End of Period  $2,249,000   $3,377,000 

 

13
 

 

Cash flows used in operating activities

 

Net cash used in operating activities increased by $373,000 during the nine months ended September 30, 2022 as compared to the nine months ended September 30, 2021 due to an increase in cash expense of approximately $403,000.

 

Cash flows used in investing activity

 

Net cash used in investing activity increased by $106,000 during the nine months ended September 30, 2022 as compared to the nine months ended September 30, 2021 due to payments for design and development work for the Company’s ASIC chip which was discontinued in the third quarter of 2022.

 

Cash flows used in financing activities

 

The Company had net cash used in financing activities during the nine months ended September 30, 2022 due to $25,000 repayment of notes payable. Conversely, it had net cash provided by financing activities during the nine months ended September 30, 2021 mainly due to proceeds from convertible promissory notes and notes payable amounting to $3,550,000 and $128,000, respectively.

 

Capital Requirements

 

The Company estimates that it will require up to $2 million of its current cash for expenses and operating costs to complete the development of a comprehensive plan for its planned clean-energy powered, containerized, immersion-cooled data center operation. Once the plans are approved for construction by the requisite authorities, the Company estimates the initial phase of its planned data center operation will cost between $60 to 75 million to build.

 

Past the plan development phase, the Company will need to raise capital in order to build its planned operations and achieve its growth targets, which the company plans to raise from investors by issuing common stock, preferred stock and/or debt securities. However, there can be no assurance that such financings will be available in sufficient amounts and on acceptable terms when it’s needed. The precise amount and timing of the funding needs cannot be determined accurately at this time, and will depend on a number of factors, including but not limited to the condition of the capital market, investor interest in our business plan, demand for the Company’s services by enterprise customers, the timing of approvals from authorities to start construction, the management of working capital, and reasonable payment terms and conditions for purchase of goods and services we will need to build our data center operation.

 

Critical Accounting Policies

 

The preparation of condensed consolidated financial statements in conformity with United States generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying disclosures of our company. Although these estimates are based on management’s knowledge of current events and actions that our company may undertake in the future, actual results may differ from such estimates.

 

Principles of Consolidation

 

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiary from the formation date. All material intercompany transactions and balances have been eliminated in consolidation.

 

Foreign Currency Translation

 

The financial statements of our foreign subsidiary, for which the functional currency is the local currency, are translated into U.S. dollars using the exchange rate at the consolidated balance sheet date for assets and liabilities and a weighted-average exchange rate during the year for revenue, expenses, gains and losses. Translation adjustments are recorded as other comprehensive income (loss) within shareholders’ equity (deficit). Gains or losses from foreign currency transactions are recognized in the consolidated statements of operations.

 

Debt and Debt Discounts

 

In accordance with ASC 470-20, Debt with Conversion and Other Options, the Company first allocates the cash proceeds of the notes between the notes and the warrants on a relative fair value basis, secondly, proceeds are then allocated to the conversion feature.

 

The Company accounts for debt discounts originating in connection with conversion features that remain embedded in the related notes in accordance with ASC 470-20. These costs are classified on the consolidated balance sheet as a direct deduction from the debt liability. The Company amortizes these costs over the term of its debt agreements as financing cost in the consolidated statement of operations.

 

Stock-Based Compensation

 

We account for our stock-based compensation under ASC 718, “Compensation – Stock Compensation” using the fair value based method. Under this method, compensation cost is measured at the grant date based on the value of the award and is recognized over the service period, which is usually the vesting period. This guidance establishes standards for the accounting for transactions in which an entity exchanges it equity instruments for goods or services. It also addresses transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity’s equity instruments or that may be settled by the issuance of those equity instruments.

 

14
 

 

We use the fair value method for equity instruments granted to non-employees and use the BSM model for measuring the fair value of options. The stock based fair value compensation is determined as of the date of the grant (measurement date) and is recognized over the vesting periods.

 

Recent Accounting Pronouncements

 

The Company’s management reviewed all recently issued accounting standard updates (“ASU’s”) not yet adopted by the Company and does not believe the future adoptions of any such ASU’s may be expected to cause a material impact on the Company’s condensed consolidated financial condition or the results of its operations.

 

Off-Balance Sheet Arrangements

 

As of September 30, 2022, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4) of Regulation S-K.

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

 

Not required under Regulation S-K for smaller reporting companies.

 

Item 4. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures

 

As of the end of the period covered by this Report, our Chief Executive Officer and Chief Financial Officer (our “Certifying Officers”), conducted evaluations of our disclosure controls and procedures. As defined under Sections 13a - 15(e) and 15d - 15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the term “disclosure controls and procedures” means controls and other procedures of an issuer that are designed to ensure that information required to be disclosed by the issuer in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission (“SEC”). Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including the Certifying Officers, to allow timely decisions regarding required disclosures.

 

Based on their evaluation, the Certifying Officers concluded that, as of September 30, 2022, our disclosure controls and procedures were not effective.

 

The material weakness related to internal control over financial reporting that was identified at September 30, 2022 was that we did not have sufficient personnel staffing in our accounting and financial reporting department. As a result, we were not able to achieve adequate segregation of duties and were not able to provide for adequate review of the financial statements.

 

This control deficiency could result in a reasonable possibility that material misstatements of the financial statements will not be prevented or detected on a timely basis. However, our management believes that the material weakness identified does not result in the restatement of any previously reported financial statements or any other related financial disclosure, and management does not believe that the material weakness had any effect on the accuracy of our financial statements included as part of this Quarterly Report.

 

We will continue to monitor and evaluate the effectiveness of our disclosure controls and procedures and our internal controls over financial reporting on an ongoing basis and are committed to taking action and implementing additional enhancements or improvements, as necessary and as funds allow.

 

Changes in internal control over financial reporting.

 

There were no changes in our internal control over financial reporting that occurred during the quarter ended September 30, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

Limitations on the Effectiveness of Internal Controls

 

Readers are cautioned that our management does not expect that our disclosure controls and procedures or our internal control over financial reporting will necessarily prevent all fraud and material error. An internal control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our control have been detected. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any control design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate.

 

15
 

 

PART II - OTHER INFORMATION

 

Item 1. Legal Proceedings

 

The pending legal proceedings as discussed in Item 3 of our Annual Report on Form 10-K for the year ended December 31, 2021 were settled during the nine months ended September 30, 2022. See Note 6 of the notes to the unaudited financial statements included in this report for a description of those proceedings and the resolution thereof.

 

Item 1A. Risk Factors

 

We are a small reporting company, as defined by Rule 12b-2 of the Exchange Act, and are not required to provide the information under this item.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

Sales of Unregistered Securities

 

There have been no sales of unregistered securities within the period covered by this report that would be required to be disclosed pursuant to Item 701 of Regulation S-K.

 

Repurchases of Shares or of Company Equity Securities

 

None.

 

Item 3. Default Upon Senior Securities

 

At September 30, 2022, the Company had outstanding promissory notes and accrued interest in the aggregate amount of $104,000 and outstanding convertible notes and accrued interest in aggregate amount of $4,806,000, all of which were past due and all of which were in default. See Notes 4 and 5 to the accompanying unaudited financial statements of the Company.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

Item 5. Other Information

 

None

 

Item 6. Exhibits

 

The following documents are filed as a part of this report or incorporated herein by reference:

 

Exhibit
Number
  Description
31.1   Certification of the Chief Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
     
31.2   Certification of the Chief Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
     
32.1   Certifications of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
     
32.2   Certifications of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
     
101.INS   Inline XBRL Instance Document.
     
101.SCH   Inline XBRL Taxonomy Extension Schema Document.
     
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document.
     
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document.
     
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document.
     
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document.
     
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

16
 

 

SIGNATURES

 

Pursuant to the requirements of Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: November 14, 2022 CalEthos, Inc.
   
  By: /s/ Michael Campbell
  Name: Michael Campbell
  Title: Chief Executive Officer
     
  By: /s/ Dean S Skupen
  Name: Dean S Skupen
  Title: Chief Financial Officer

 

17